How We Operate

Research and Development

From API screening to product lifecycle management

Osgen works with clients at each stage of the product development journey, from supporting initial compound selection decisions through to re-purposing of therapeutics to extend sales in the marketplace. Typical projects undertaken include:

  • Removal of impurities and residual solvent from early experimental material

  • Enhanced polymorph screens including isolation of high pressure polymorphs which can only be found using SCF techniques

  • Generation of crystalline material and crystallisation seeds

  • Co-crystal screens to generate scalable co-crystals

  • Improving solubility through changes in particle size and morphology, solid form, stabilisation of amorphous forms, or co-crystallisation

  • Enhancing permeability through modification of particle surface chemistry or creation of composite API-enhancer particles

  • Improving retained activity and ease of reconstitution of biotherapeutics (e.g. peptides, proteins)

  • Design of particles for enhanced delivery or performance (e.g. inhaled, taste masking)

  • Reducing cost of goods through design of high-yielding, single-step processes and products requiring fewer excipients

  • Supply of GMP material for clinical trials

Innovation & Technology Development

Continuously improving the capability of the mSAS® process

Osgen invests its own resources and works in partnership with scientific partners worldwide to continuously develop the capability of mSAS® (modified supercritical anti-solvent). This work has delivered major advances, most notably in expanding the range of small and large molecule therapeutics that can be successfully processed using this technology. Examples of ongoing innovation and technology development projects include:

  • Development of fully-scalable nozzle technologies

  • Optimisation of CO2 and process flow control systems

  • Optimisation of vessel geometries

  • Crystal nucleation studies

  • Identification of a suitable scalable co-crystal template library

  • Selection of transient modification agents to enable control of particle habit

  • Evaluation of surface modification agents to reduce aggregation or promote absorption

The Osgen team has the longest experience of working with SCF technology in pharmaceutical and crystal engineering. Our goal is to maintain a leading position in the application of this technology and in so doing deliver health benefits to patients worldwide.

 

In-House Product Development

Osgen is investing in the development of its own portfolio of improved or repurposed generic products. Each of these products is exploiting specific advantages of mSAS® technology, whether in designing particles capable of unprecedented levels of deep lung deposition or nasal retention, or the creation of a new generation of room temperature-stable, readily-reconstituted biotherapeutic products. In all cases, the Osgen team ensures that its own activities do not conflict with the interests of its clients.

Examples of products in development include:

  • The first on-demand drug treatment for urge incontinence

  • A rapidly acting therapy for Raynaud’s disease

  • A rescue therapy for menorrhagia (heavy periods)

  • A novel combination treatment for COPD (Chronic Obstructive Pulmonary Disease)

  • An improved therapeutic for ischemic stroke

  • Improved, high quality formulation of Traditional Chinese Medicine

 
 

Payment Terms

We are pleased to offer you the convenience of our Payment on Delivery (POD) service available to all our supply agents and investors. This policy outlines the terms and conditions for payments made upon receipt of goods or services by Osgen Pharmaceuticals UK. - Our Pay on Delivery service is available for all products and services.

Verification: - Our procurement personnel will verify the order details and the total amount due upon arrival. - Please be rest assured that all payments would be released from the finance department 3-5 days after supply.

Receipt and Acknowledgment: - Upon receiving goods; our procurement personnel will provide a receipt for your records.

Terms and Conditions: - This Payment on Delivery policy is subject to change without prior notice. It is recommended to review this policy periodically for any updates. Please do not hesitate to contact our customer support team if you have any questions or inquiries - info@osgenpharma.uk Thank you for choosing Osgen Pharmaceuticals UK.

To keep up to date with the latest news from Osgen, please follow us on LinkedIn.